>*e IFEMALES OF CHILDBEARING POTENTIAL the patient qualifies for therapyaccording to the followingcriteria: Site must have severe, disfiguring cystic acne tlwtt is unresponsive to standard therapies. She must be reliable and capable o f practicing cflcctfvc contraception. In addition, pregnancy must be ruled out with a serum pregnancy test within two weeks ofbegin- ning therapy. She must receive written and oral warnings that Accutane* (isotretinoin'Roche) can cause severe fetal abnormalities, and tliat there isa risko f possible contraception failure. Sheshoukl also signa consent form tlvit cnipliasizcs the risks six* is assuming, as well as herresponsibility toavoid pregnancy. Finally, slie should commence therapyonly on the second or third day o f her next normal menstrual period. While using these criteria may lengthen tlic processo f prescribingAccutane, we feci there is no altcmatrre with females of child- liearing potential. Roche Dermatologies a dwsion ot HctfciarevU Roche Inc. Who should prescribe Accutane shoultl Ix: jnvscribcd only by physicians who Ilave special competence in the diagnosis and treatment of.severe recalcitrant cystic acne. They sluruld be experienced in the tuseo f systemic retinoids and haw an understanding o f tlx; ixitciuivil teratogenic risk o f using j Accutane during pregnancy. For those physicians with systemic retinoid experience, a new Pregnancy' Prevention Program is nowavailable. It'sdesigned as a comprehensive, step-by-step aid to patient selection and counseling. Since introducingAccutane, Roche warned o f the potential teratogenic riskand has emphasized appropriate product information. The new program continues this long-standingpolicy* and we believe it will serve the best interests o f both the patient and physician. Accutane(IxHrcliiwIjvXixlic) rr by fomntcawtioare Pregnant, who intend to Iwomc pregnant wjittc undergoingtreatment, or who an?uiuvlinbtcor mnv not i i * rrtwfcSc contraception forcnc month before treatment, duringtreatment and for one monthafter ireatinent. Accutane i* COntndodkatcd in of chQdbcttringpotential unless the A guide to the types of patients who need Peridex: Gingival bleeders Despite your best efforts, many of your patients continue to display bleeding gums on recall. And that calls for serious medicine... PERIDEX* (chlortiexidine gluoonatc 0.12%) Oral Rinse—the strength you need to treat gingival bleeding. When used adjunctively with brushing and flossing, PERIDEX" helps promote healing, as demonstrated by its ability to significantly reduce bleeding sites and inflammation due to gingivitis' Gums that bleed heal better with
RkJQdWJsaXNoZXIy NDMwNDAx